| Literature DB >> 33479663 |
Xuan Yang1,2, Haian Fu1,2,3,4, Andrey A Ivanov1,2,3.
Abstract
The advances in cancer genomics, chemical biology, high-throughput screening technologies, and synthetic medicinal chemistry have tremendously expanded the biological space of cancer targets and chemical space of bioactive small molecules to interrogate oncogenic signaling. To explore and leverage these exponentially growing cancer-associated data, a great number of computational tools, databases, and algorithms have been developed. This review summarizes recent cancer-related web resources that allow researchers working at the interface of chemical, biological, and cancer genomics fields to integrate clinical and genomics data for specific actionable targets and selective chemical compounds to facilitate cancer therapeutic discovery. This journal is © The Royal Society of Chemistry 2020.Entities:
Year: 2020 PMID: 33479663 PMCID: PMC7429978 DOI: 10.1039/d0md00012d
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682